RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 901–1,000 of 1,009
MHC homologs in the nervous system — they haven’t lost their groove
Olson, R., Dulac, C. G., & Björkman, P. J. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.007 · Cited by 35
Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor
Kleinau, G., Heyder, N., Tao, Y., & Scheerer, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165728 · Cited by 34
Aging-related modifications to G protein-coupled receptor signaling diversity
van Gastel, J., Leysen, H., Boddaert, J., Vangenechten, L., Luttrell, L. M., Martin, B., & Maudsley, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107793 · Cited by 32
Martins-Oliveira, M., Tavares, I., & Goadsby, P. J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147629 · Cited by 34
“…spanning protein (calcitonin receptor-like receptor; CLR) and a single transmembrane receptor modifying protein (RAMP) 1 (Aiyar et al., 1996; McLatchie et al., 1998); and may act at another, the non-canonical amylin receptor (AMY1) that consists of the calcitonin receptor (CTR) and RAMP1…”
BackgroundBraco, J. T., Saunders, C. J., Nelson, J. M., & Johnson, E. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084266 · Cited by 33
“Alternatively, classes of proteins may directly modify the activity and localization through posttranslational modifications of the GPCR (RAMPS and RGS) [29,30].”
BackgroundHwang, I. S. S., Autelitano, D. J., Wong, P. Y. D., Leung, G., & Tang, F. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.011015 · Cited by 32
“[24], CRLR can function as a CGRP receptor in the presence of RAMP1 or as an AM receptor in the presence of RAMP2 or RAMP3.”
BackgroundLewis, C. J., Gong, H., Brown, M. J., & Harding, S. E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705668 · Cited by 32
“…effects of the low-affinity state of the b1-adrenoceptor could occur by interaction with other accessory proteins, possibly in a similar manner to receptor activity modifying proteins (McLatchie et al., 1998), post-translational modifications or conforma- tional changes (Konkar et al., 2000b).”
BackgroundZaarour, N., Demaretz, S., Defontaine, N., Zhu, Y., & Laghmani, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399162 · Cited by 33
“Moreover, the (1038)LL(1039), (1048)LI(1049), and (1081)LLV(1083) motifs may also provide interactive sites mediating the interaction of the co-transporter with selective and specific proteins, such as KChlPI for the Kv4 potassium channel (57), RAMP for the calcitonin receptor-like receptor (58) and RanBP2 for opsin (…”
BackgroundKwon, H., Lu, H., Longnecker, M. T., & Pietrantonio, P. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050374 · Cited by 32
“of hRAMPs for activation [21] and, 3) that AaegGPRCAL1 is glycosylated, and receptor glycosylation is critical for hRAMPs interactions with hCALCRL [20].”
BackgroundThe nuclear localization of WAP and CSN genes is modified by lactogenic hormones in HC11 cells
Ballester, M., Kress, C., Hue‐Beauvais, C., Kiêu, K., Lehmann, G. G., Adenot, P. G., & Devinoy, È. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21823 · Cited by 33
“It is located between two genes (TBRG4 and RAMP3) which are expressed in several tissues [McLatchie et al., 1998; Rival-Gervier et al., 2003] that are not regulated by lactogenic hormones.”
BackgroundFernández, A. P., Serrano, J., Martínez‐Murillo, R., & Martínez, A. (2010) · Endocrinology · doi:10.1210/en.2010-0121 · Cited by 32
“ceptor activity modifying protein (RAMP) type 2 or 3 (2).”
BackgroundG-protein-Coupled Receptors and Their (Bio) Chemical Significance Win 2012 Nobel Prize in Chemistry
Lin, H. (2013) · Biomedical Journal · doi:10.4103/2319-4170.113233 · Cited by 41
GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs
Barbash, S., Lorenzen, E., Persson, T., Huber, T., & Sakmar, T. P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713074114 · Cited by 32
“Several GPCRs were previously shown to interact with RAMPs; these include the calcitonin and CALCRL, the secretin receptor (22), vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor, parathyroid hormone receptors, and glucagon receptor (2, 23).”
BackgroundZhang, M., & Wu, G. (2018) · Traffic · doi:10.1111/tra.12624 · Cited by 35
Development of angiotensin II-induced hypertension: role of CGRP and its receptor
Li, J., & Wang, D. H. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00020 · Cited by 32
Zhou, Z., Peng, J., Ye, F., Li, N., Deng, H., & Li, Y. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0537-y · Cited by 32
“Previous studies have suggested that there are no distinguishable differences in biological activity between α - and β-CGRP ( McLatchie et al. 1998 ).”
Schwarz, N., Renshaw, D. W., Kapas, S., & Hinson, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06806 · Cited by 32
“AM exerts its effects via the G-protein coupled calcitoninlike receptor (CL) complexed with a receptor accessory modifying protein known as receptor activity modifying protein (RAMP) 2 (AM1 receptor) or RAMP 3 (AM2 receptor) (McLatchie et al. 1998, Poyner et al. 2002).”
BackgroundAiyar, N. V., Disa, J., Pullen, M. A., & Nambi, P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011907328682 · Cited by 37
“An accessory protein called receptor activity modifying protein (RAMP) confers receptor specificity for ADM or CGRP [13].”
BackgroundArgunhan, F., & Brain, S. D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.833645 · Cited by 31
“Upon activation of the CRLR/RAMP1 receptor, G-protein induced signaling cascade is initiated, with Gαs-induced cyclic adenosine monophosphate (cAMP) being the major secondary messenger involved (McLatchie et al., 1998; Pioszak and Hay, 2020).”
BackgroundMétellus, P., Voutsinos‐Porche, B., Nanni‐Metellus, I., Colin, C., Fina, F., Berenguer‐Daizé, C., Dussault, N., Boudouresque, F., Loundou, A., Intagliata, D., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.02.021 · Cited by 31
Amylin in the Periphery II: An Updated Mini-Review
Wookey, P. J., Lutz, T. A., & Andrikopoulos, S. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.263 · Cited by 32
“RAMPs interact with many members of the Group B GPCRs and appear to be generally involved in the cycling of these GPCRs to and from the plasma membrane destined for several cytoplasmic targets, depending on the type of RAMP (1, 2, or 3) heterodimer[70].”
BackgroundBiological properties of adrenomedullin conjugated with polyethylene glycol
Kubo, K., Tokashiki, M., Kuwasako, K., Tamura, M., Tsuda, S., Kubo, S., Yoshizawa‐Kumagaye, K., Kato, J., & Kitamura, K. (2014) · Peptides · doi:10.1016/j.peptides.2014.05.005 · Cited by 34
Diabetic neuropathy and heart failure: role of neuropeptides
Ejaz, A., LoGerfo, F. W., & Pradhan, L. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001979 · Cited by 31
Depressed perivascular sensory innervation of mouse mesenteric arteries with advanced age
Boerman, E. M., & Segal, S. S. (2015) · The Journal of Physiology · doi:10.1113/jp270710 · Cited by 33
“The functional CGRP receptor requires three subunits: (1) calcitonin receptor-like receptor (CRLR) protein, (2) a chaperone known as receptor activity modifying protein (RAMP1) and (3) receptor component protein (McLatchie et al. 1998).”
BackgroundCurrent and prospective pharmacological targets in relation to antimigraine action
Mehrotra, S., Gupta, S. K., Chan, K. Y., Villalón, C. M., Centurión, D., Saxena, P. R., & MaassenVanDenBrink, A. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0322-7 · Cited by 34
Anti‐Inflammatory Effects of PEGylated Human Adrenomedullin in a Mouse DSS‐Induced Colitis Model
Nagata, S., Yamasaki, M., & Kitamura, K. (2017) · Drug Development Research · doi:10.1002/ddr.21383 · Cited by 35
“hAM and hAM receptor expression has been shown to be widely distributed in gastrointestinal tissues including the stomach, duodenum, jejunum, ileum, colon, and rectum [McLatchie et al., 1998; Hay and Smith, 2001].”
BackgroundAdrenomedullin in lymphangiogenesis: from development to disease
Klein, K. R., & Caron, K. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1921-3 · Cited by 31
GPCR Interacting Proteins: Classes, Assembly, and Functions
Wang, H., Willmore, C. B., & Wang, J. B. (2005) · Contemporary clinical neuroscience · doi:10.1007/978-1-59259-919-6_9 · Cited by 31
“CRLR can be co-expressed with RAMP1 to form functional CGRP receptors, and CRLR co-expression with RAMP2 or -3 promoted the formation of a receptor with pharmacological properties of an adrenomedullin receptor ( 7 ,44).”
BackgroundAlternative drug discovery approaches for orphan GPCRs
Levoye, A., & Jockers, R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.011 · Cited by 31
Howitt, S. G., Kilk, K., Wang, Y., Smith, D. M., Langel, Ü., & Poyner, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705040 · Cited by 32
“The best characterized of these is the CGRP1 receptor, formed of a complex between the heptahelical calcitonin receptor- like receptor (CRLR) and receptor activity modifying protein 1 (RAMP1), a protein with a single transmembrane helix (McLatchie et al., 1998).”
BackgroundThe pharmacology of CGRP-responsive receptors in cultured and transfected cells
Hay, D. L., Conner, A. C., Howitt, S. G., Takhshid, M. A., Simms, J., Mahmoud, K., & Poyner, D. R. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.007 · Cited by 31
Gangula, P. R., Thota, C., Wimalawansa, S. J., Bukoski, R. D., & Yallampalli, C. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.016725 · Cited by 31
“PCR reactions were initiated by the specific primer sets for CRLR, RAMP1 [24], and 18S rRNA (Ambion Inc.”
MethodSerial analysis of gene expression in normal p53 null mammary epithelium
Aldaz, C. M., Hu, Y., DANIEL, R. L., Gaddis, S., Kittrell, F. S., & Medina, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205816 · Cited by 31
“It is postulated that the specific Ramp member – Crlr combination defines the ligand affinity of the receptor for either Calcitonin or Adrenomedullin (Adm) (McLatchie et al., 1998).”
BackgroundKuwasako, K., Kitamura, K., Nagata, S., Hikosaka, T., & Kato, J. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.005 · Cited by 30
Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina
Blixt, F. W., Radziwon‐Balicka, A., Edvinsson, L. I., & Warfvinge, K. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.06.002 · Cited by 30
CGRP, Amylin, Immunology, and Headache Medicine
Taylor, F. R. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13432 · Cited by 31
Grossini, E., Molinari, C. G., Mary, D., Uberti, F., Caimmi, P. P., & Vacca, G. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00569.2009 · Cited by 30
“A membrane-associated receptor component protein and receptor activity-modifying proteins (RAMPs) are required for the optimum activation of signal transduction (42, 34).”
BackgroundLi, Y., Li, L., Hwang, I. S. S., Tang, F., & Wai‐Sum, O. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.064022 · Cited by 32
“Coexpression of CALCRL with RAMP1 gives rise to a CALCA receptor, whereas with RAMP2 or RAMP3 it results in an ADM receptor [8, 29, 30].”
Mapping the calcitonin receptor in human brain stem
Bower, R. L., Eftekhari, S., Waldvogel, H. J., Faull, R. L. M., Tajti, J., Edvinsson, L. I., Hay, D. L., & Walker, C. S. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00539.2015 · Cited by 30
“CTR with RAMP1 responds potently to both amylin and CGRP.”
BackgroundInfluentialGarcía‐Ponce, A., Chánez-Paredes, S. D., Castro-Ochoa, K. F., & Schnoor, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1228439 · Cited by 34
“Importantly, RAMP2 was not able to respond without CRLR, and HEK294T cells that co-expressed CRLR and RAMP2 were able to induce cAMP production upon ADM stimulation.(64) Recently, the activity of RAMP2 was found to be important for EC viability, integrity and homeostasis.”
BackgroundInfluentialMinatani, A., Uchida, K., Inoue, G., Takano, S., Aikawa, J., Miyagi, M., Fujimaki, H., Iwase, D., Onuma, K., Matsumoto, T., et al. (2016) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-016-0460-4 · Cited by 30
“RAMP1 is required for the translocation of CLR to the cell surface and also participates in ligand binding and is therefore essential for CGRP receptor signaling [22, 23].”
BackgroundThe role of neuropeptides in adverse myocardial remodeling and heart failure
Widiapradja, A., Chunduri, P., & Levick, S. P. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2452-x · Cited by 31
“There are three RAMP isotypes, RAMP1, RAMP2 and RAMP3 [9, 10].”
Manoukian, R., Sun, H. Q., Miller, S., Shi, D., Chan, B., & Xu, C. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0992-1 · Cited by 30
Refining Efficacy: Exploiting Functional Selectivity for Drug Discovery
Gesty‐Palmer, D., & Luttrell, L. M. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00009-9 · Cited by 30
“For example, receptor activity-modifying proteins (RAMPs) and receptor component protein form obligate complexes with the calcitonin receptor-like receptor (CRLR) and calcitonin receptor that define the ligand binding specificity of the receptor (Evans et al., 2000; McLatchie et al., 1998).”
BackgroundAdrenomedullin and adrenomedullin binding protein-1: their role in the septic response
Fowler, D. E., Yang, S., Zhou, M., Chaudry, I., Simms, H. H., & Wang, P. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00086-0 · Cited by 37
Parker, R. M. C., Copeland, N. G., Eyre, H. J., Liu, M., Gilbert, D. J., Crawford, J., Couzens, M., Sutherland, G. R., Jenkins, N. A., & Herzog, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00052-8 · Cited by 30
Tam, C. W., & Brain, S. D. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:117 · Cited by 33
“The effects of CGRP are blocked by CGRP8–37 (Chiba et al., 1989) and the nonpeptide CGRP antagonist BIBN4096BS (Doods et al., 2000), whereas the AM receptor is blocked by the relatively weak antagonist AM22–52 (McLatchie et al., 1998).”
Adrenomedullin prevents apoptosis in prostate cancer cells
Abasolo, I., Montuenga, L. M., & Calvo, A. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.09.026 · Cited by 30
“CL requires the presence of RAMPs for intracellular signaling [15].”
Dvorakova, M. C., Kuncová, J., Pfeil, U., McGregor, G. P., Švíglerová, J., Slavíková, J., & Kummer, W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.058 · Cited by 30
Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes
Inaba, C., Nishikimi, T., Akimoto, K., Yoshihara, F., Minamino, N., & Matsuoka, H. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90467.2008 · Cited by 31
Koller, D., Born, W., Leuthäuser, K., Flühmann, B., McKinney, R. A., Fischer, J. A., & Muff, R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03585-8 · Cited by 30
Li, Y., Hwang, I. S. S., Wai‐Sum, O., & Tang, F. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.052274 · Cited by 30
“It is well established that the calcitonin receptor-like receptor CALCRL accounts for the majority of ADM and CALCA binding, and whether it binds to ADM or to CALCA depends on the type of receptor activity modifying protein (RAMP) that is expressed [8], namely, RAMP1, RAMP2, or RAMP3.”
BackgroundThe adrenomedullin receptor acts as clearance receptor in pulmonary circulation
Dschietzig, T. B., Azad, H. A., Asswad, L., Böhme, C., Bartsch, C., Baumann, G., & Stangl, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00474-6 · Cited by 30
“These two AM-binding receptors are expressed from the calcitoninreceptor-like receptor (CRLR) gene: in the presence of the receptor activity-modifying protein-1 (RAMP1), the CRLR functions as CGRP1R; in coexpression with RAMP2 or RAMP3, CRLR becomes an AMR [4].”
BackgroundAdrenomedullin promotes epithelial restitution of rat and human gastric mucosa in vitro
Fukuda, K., Tsukada, H., Oya, M., Onomura, M., Kodama, M., Nakamura, H., Hosokawa, M., & Seino, Y. (1999) · Peptides · doi:10.1016/s0196-9781(98)00146-6 · Cited by 31
Chu, D. Q., Choy, M., Foster, P., Cao, T. V., & Brain, S. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703502 · Cited by 36
“The role of the RAMPs is considered to be to control the transport and glycosylation of the CRLR. McLatchie et al. (1998) suggest that RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor.”
BackgroundMarie, J.-C., Wakkach, A., Coudray, A.-M., Chastre, E., Berrih‐Aknin, S., & Gespach, C. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2103 · Cited by 30
Autelitano, D. J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9375 · Cited by 32
Localization of calcitonin gene-related peptide receptors in rat gastric mucosa
Kawashima, K., Ishihara, S., Rumi, M. A. K., Moriyama, N., Kazumori, H., Suetsugu, H., Satō, H., Fukuda, R., Adachi, K., Shibata, M., et al. (2002) · Peptides · doi:10.1016/s0196-9781(02)00019-0 · Cited by 30
Adrenomedullin: An Autocrine/Paracrine Factor for Cardiorenal Protection
Tsuruda, T., & Burnett, J. C. J. (2002) · Circulation Research · doi:10.1161/01.res.0000015462.11528.28 · Cited by 31
“To date, the role of AM as an autocrine or paracrine factor has been studied using receptor antagonists, such as calcitonin gene–related peptide (CGRP), type 1 receptor antagonist [human CGRP (8-37)], the N-terminal–deleted form of AM [human AM (22-52)], and AM monoclonal antibodies for neutralizing AM biological acti…”
Inclan-Rico, J. M., Napuri, C. M., Lin, C., Hung, L., Ferguson, A. A., Liu, X., Wu, Q., Pastore, C., Stephenson, A., Femoe, U. M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01982-y · Cited by 31
Blocking Neurogenic Inflammation for the Treatment of Acute Disorders of the Central Nervous System
Lewis, K., Turner, R. J., & Vink, R. (2013) · International Journal of Inflammation · doi:10.1155/2013/578480 · Cited by 35
The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach
Woolley, M. J., Watkins, H. A., Taddese, B., Karakullukcu, Z. G., Barwell, J., Smith, K. J., Hay, D. L., Poyner, D. R., Reynolds, C. A., & Conner, A. C. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0589 · Cited by 32
Dunworth, W. P., & Caron, K. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185066 · Cited by 29
CGRP-Based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
Russo, A. F. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00036 · Cited by 34
Ji, Y., Rizk, A. M., Voulalas, P. J., Aljohani, H., Akerman, S., Dussor, G. O., Keller, A., & Masri, R. M. (2019) · Neurobiology of Pain · doi:10.1016/j.ynpai.2019.100031 · Cited by 30
“CGRP acts by activating a receptor that is a heterodimer of two membrane proteins: calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) (McLatchie et al., 1998; Dickerson, 2013; Edvinsson and Warfvinge, 2013).”
BackgroundInfluentialMoore, E. L., Burgey, C. S., Paone, D. V., Shaw, A. W., Tang, Y. S., Kane, S. A., & Salvatore, C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.050 · Cited by 29
Barrick, C. J., Lenhart, P., Dackor, R. T., Nagle, E., & Caron, K. M. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.10.021 · Cited by 29
Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism
Sekine, N., Takano, K., Kimata-Hayashi, N., Kadowaki, T., & Fujita, T. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2005 · Cited by 30
“Because adrenomedullin receptors are known to couple to G proteins (9, 15), the inhibitory effect of adrenomedullin on insulin secretion was believed to be mediated by a PTX-sensitive G protein (22).”
BackgroundAdrenomedullin Relaxes Rat Uterine Artery: Mechanisms and Influence of Pregnancy and Estradiol
Ross, G. R., Yallampalli, U., Gangula, P. R., Reed, L. C., Sathishkumar, K., Gao, H., Chauhan, M., & Yallampalli, C. (2010) · Endocrinology · doi:10.1210/en.2010-0096 · Cited by 31
“AM signaling is regulated by a unique system of receptors consisting of a seven-membrane domain G proteincoupled receptor named calcitonin receptor-like receptor (CL) associated with an accessory protein, receptor-activity-modifying protein (RAMP) (22).”
BackgroundGrant, A. D., Tam, C. W., Lázár, Z., Shih, M. K., & Brain, S. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705824 · Cited by 29
“The dominant receptor for AM is thought to be CL/RAMP2 (McLatchie et al., 1998), while that for CGRP is CL/RAMP1 receptor (McLatchie et al., 1998).”
BackgroundXu, Y., & Krukoff, T. L. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.12.018 · Cited by 30
Udono‐Fujimori, R., Udono, T., Totsune, K., Tamai, M., Shibahara, S., & Takahashi, K. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00027-2 · Cited by 35
Pokabla, M. J., Dickerson, I. M., & Papka, R. E. (2002) · Peptides · doi:10.1016/s0196-9781(01)00638-6 · Cited by 30
Adrenomedullin in mammalian embryogenesis
Garayoa, M., Bodegas, M. E., Cuttitta, F. F., & Montuenga, L. M. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10050 · Cited by 33
“Both human RAMP2 and RAMP3 mRNA have also been shown to be abundantly represented in human placenta as assessed by Northern blot analysis (McLatchie et al., 1998).”
BackgroundAdrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression
Autelitano, D. J., & Ridings, R. (2001) · Peptides · doi:10.1016/s0196-9781(01)00536-8 · Cited by 31
Sutherland, H. G. E., Buteri, J., Menon, S., Haupt, L. M., MacGregor, E. A., Lea, R. A., & Griffiths, L. R. (2012) · Gene · doi:10.1016/j.gene.2012.11.053 · Cited by 28
Desai, A. J., Roberts, D. J., Richards, G. O., & Skerry, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085237 · Cited by 28
“It was discovered that the ‘‘CGRP receptor’’ was a heteromer of the calcitonin-like receptor (CLR) and RAMP1.”
BackgroundInfluentialCalcitonin Gene-Related Peptide (CGRP) in Cerebrovascular Disease
Edvinsson, L. I. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.806 · Cited by 28
“McLatchie and coworkers[18] demonstrated that functional CGRP1 and adrenomedullin receptors are both derived from CRLR and that the phenotype is determined by coexpression with a particular receptor activity modifying protein, RAMP.”
BackgroundAdrenomedullin regulates intestinal physiology and pathophysiology
Martínez-Herrero, S., & Martínez, A. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.02.004 · Cited by 30
Zhang, Q., Guo, Y., Yu, H., Tang, Y., Yuan, Y., Jiang, Y., Chen, H., Gong, P., & Xiang, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28082 · Cited by 28
Tringali, G., & Navarra, P. (2019) · Peptides · doi:10.1016/j.peptides.2019.04.012 · Cited by 28
Zaki, M., Koduru, S., McCuen, R. W., Vuyyuru, L., & Schubert, M. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.34176 · Cited by 28
Regulation of Oocyte and Cumulus Cell Interactions by Intermedin/Adrenomedullin 2
Chang, C. L., Wang, H., Soong, Y., Huang, S. Y., Pai, S. Y., & Hsu, S. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297358 · Cited by 28
Lafont, A.-G., Dufour, S., & Fouchereau‐Péron, M. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.01.027 · Cited by 28
Dong, Y.-L., Vegiraju, S., Chauhan, M., & Yallampalli, C. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag058 · Cited by 30
“It is well recognized that calcitonin receptor-like receptor (CRLR) can function as either a CGRP receptor or an adrenomedullin receptor depending on the expression of the type of receptor activity modifying protein (RAMP) (McLatchie et al., 1998).”
BackgroundMethodInfluentialBarwell, J., Wootten, D. L., Simms, J., Hay, D. L., & Poyner, D. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_2 · Cited by 30
Fukai, N., Shichiri, M., Ozawa, N., Matsushita, M., & Hirata, Y. (2003) · Endocrinology · doi:10.1210/en.2002-220463 · Cited by 28
“Recently three isoforms of receptor activity-modifying protein (RAMP) were isolated (15).”
BackgroundCalcitonin gene‐related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine
Brain, S. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705806 · Cited by 28
“This antagonist is selective for the heterodimer CGRP receptor which is composed of a 7-transmembrane Gprotein-linked component (calcitonin receptor-like receptor, CL) and also requires a receptor activity membrane protein (RAMP1) for functional acivity (McLatchie et al., 1998).”
BackgroundGörbig, M. N., Ginès, P., Bataller, R. A., Nicolás, J. M., García-Ramallo, E., Cejudo, P., Sancho‐Bru, P., Jiménez, W., Arroyo, V., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00016-7 · Cited by 31
Sensitivity of myometrium to CGRP varies during mouse estrous cycle and in response to progesterone
Naghashpour, M., & Dahl, G. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.3.c561 · Cited by 28
Evidence for the existence of a new receptor for CGRP, which is not CRLR
Chauhan, M., Thota, C. S., Kondapaka, S. B., Wimalawansa, S. J., & Yallampalli, C. (2003) · Peptides · doi:10.1016/s0196-9781(02)00277-2 · Cited by 28
Koller, D., Ittner, L. M., Muff, R., Husmann, K., Fischer, J. A., & Born, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313058200 · Cited by 28
Mechanisms and Functions of Sweet Reception in Oral and Extraoral Organs
Yoshida, R., & Ninomiya, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137398 · Cited by 35
Brain-wide mapping of c-Fos expression in nitroglycerin-induced models of migraine
Xiao, S., Lu, G., Liu, J., Su, W., Li, C., Liu, Y., Meng, F., Zhao, J., Gao, N., Chang, Y. Z., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01837-9 · Cited by 27
“CGRP receptors are widely expressed in the rodent brain, and the discovery of CGRP receptor elements, namely calcitonin receptor-like receptor and receptor activity-modifying protein 1, has propelled advancements in this field [51, 52].”
BackgroundWang, Z., Martorell, B. C., Wälchli, T., Vogel, O., Fischer, J. A., Born, W., & Vogel, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123697 · Cited by 27
“The receptors for these peptides are heterodimers of the calcitonin receptor-like receptor (Calclr) and either the receptor-activity modifying protein (RAMP)-1 or -2 forming at the cell surface a receptor for CGRP or AM, respectively [13].”
BackgroundDai, K., Tanaka, M., Kamiyoshi, A., Sakurai, T., Ichikawa‐Shindo, Y., Kawate, H., Cui, N., Wei, Y., Tanaka, M., Kakihara, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1112-z · Cited by 27
“The ligand-specific functions of CLR are regulated by a group of three membrane proteins, receptor activity-modifying proteins 1–3 (RAMP1–3), which bind CLR one-to-one [14].”
BackgroundFoll, C. L., & Lutz, T. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190034 · Cited by 27
Zhang, Y., Lin, C., Wang, X., & Ji, T. (2020) · Oncology Letters · doi:10.3892/ol.2020.12116 · Cited by 30
“RAMP1s are small membrane proteins that possess a large extracellular NH2 terminus of 100 amino acids, a single transmembrane domain and a short intracellular domain of 10 amino acids (19).”
BackgroundInhibition of CGRP signaling impairs fracture healing in mice
Wee, N. K. Y., Novak, S., Ghosh, D., Root, S. H., Dickerson, I. M., & Kalajzić, I. (2022) · Journal of Orthopaedic Research® · doi:10.1002/jor.25474 · Cited by 27
“activity modifying protein 1 (RAMP1), and receptor complex protein (receptor component protein [RCP]).(18,19) The specificity of CGRP/ CLR/RAMP1 is defined by the interaction of CGRP–RCP.”
BackgroundTixier, E., Leconte, C., Touzani, O., Roussel, S., Petit, E., & Bernaudin, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05494.x · Cited by 27
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.